AuroSource's contract services cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for Penicillin's (sterile and non-sterile), cephalosporins (sterile and non-sterile) and non betalactams. Aurobindo has believed in the strength of technology and evolution of science for a healthy living since its inception in 1986, and AuroSource couples that belief with the commitment to compromise nothing.
We are committed to execute each and every project in a seamless manner. Aurobindo's product breadth and expertise allow us to provide multiple outsourcing benefits to our customers. We offer specialized capabilities with extensive regulatory, and R&D experience from the clinical to the post patent expiry phase of a product.
AuroSource offers comprehensive outsourcing options in registered starting materials, intermediates and APIs along with stability study activities. Advance intermediates and API can be developed and commercially manufactured on an exclusive basis based on a mutually agreeable supply contract.
We foster Development and scale up of non infringing routes for our customers. We also offer solutions to manage the complete product lifecycle including extensions and regulatory support.
In stability studies we offer our services for Drug Substance and Drug Products.
We aim to achieve the goals for wider access...ARVs / HIVs
Aurobindo has evolved into a knowledge driven...Strategic Alliance
Our Corporate Social Responsibility includes...Social Responsibility
Aurobindo Pharma has a team of more than...Global Family
Financial Results of Aurobindo Pharma...Investor Relations